Intermittent Bolus Doses of Phenylephrine, Norepinephrine and Ephedrine for the Management of Spinal Induced Hypotension in Preeclamptic Patients

NCT07795710 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2026-08-31

No results posted yet for this study

Summary

intermittent bolus doses of phenylephrine, norepinephrine and ephedrine for the management of spinal induced hypotension in preeclamptic patients

Conditions

  • Ephedrine
  • Norepinephrine

Interventions

DRUG

Group 1 (P)

receive bolus dose of phenyelepherine 75 ug

DRUG

Group 2( N)

Group 2( N) will receive bolus dose of noradrenaline 4 ug

DRUG

Group 3( E)

Group 3( E) will receive bolus dose ephedrine 4 mg

Sponsors & Collaborators

  • Minia University

    lead OTHER

Principal Investigators

  • Ali Ali, Assistant lecturer · Assistant lecturer

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-30
Primary Completion
2024-01-30
Completion
2024-01-30

Countries

  • Egypt

Study Locations

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07795710 on ClinicalTrials.gov